A recent review in the Journal of Medicinal Chemistry looked at over 120 clinical trials of curcumin, the major chemical component of turmeric. The authors conclude: “No double-blinded, placebo controlled clinical trial of curcumin has been successful… Curcumin is an unstable, reactive, nonbioavailable compound and, therefore, a highly improbable lead.” Curcumin is an experimental agent—it isn’t FDA approved to prevent or treat any disease. In fact, the FDA listed curcumin on its website as one of “187 Fake Cancer ‘Cures’ Consumers Should Avoid.”
